Genotype reduces bleeding risk
Links shared publicly online about this topic.
- 1,715total visits
Genotype reduces bleeding risk
View full resource at theheart.org
Tags: Bleeding
Most Recently Shared on September 28, 2009 at 6:44 pm By:
heartwire: CHARISMA Genomics Substudy links loss-of-function allele and bleeding http://bit.ly/2iIgcb
Pre-PCI bleeding risk score predicts greater risk, higher costs
medicalxpress.com — “A pre-procedure bleeding risk score can accurately identify high-risk, high-cost patients and may provide an opportunity to employ bleeding avoidance strategies to improve patient outcomes and reduce total costs related to percutaneous coronary intervention (PCI) procedures, according to a retrospective ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 3:07 pm By:
PhysOrg Health News Health News
Pre-PCI bleeding risk score predicts greater risk, higher costs http://t.co/MLrY8oey
Merck blood thinner shows mixed results: study
medicalxpress.com — “An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.” View full resource at medicalxpress.com
Most Recently Shared on March 24, 2012 at 11:10 pm By:
PhysOrg Health News Health News
Merck blood thinner shows mixed results: study http://t.co/EL54QHbw
Merck blood thinner shows mixed results: study
health.yahoo.net — “An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 9:40 pm By:
Merck blood thinner shows mixed results: study http://t.co/2ufXHF4G
Merck blood thinner shows mixed results: study
health.yahoo.net — “An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 8:29 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Merck blood thinner shows mixed results: study: An experimental blood thinning drug made by the pharmaceutical g... http://t.co/fomhfo8e
Merck blood thinner shows mixed results: study
health.yahoo.net — “An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 8:09 pm By:
Jane Anderson Healthy Eating Advisor
Merck blood thinner shows mixed results: study http://t.co/ML6S5o3a
Merck blood thinner shows mixed results: study - Yahoo! News
news.yahoo.com — “From Yahoo! News: An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.” View full resource at news.yahoo.com
Most Recently Shared on March 24, 2012 at 6:30 pm By:
HealthTrendster Health Executive
Merck 'blood thinner' shows mixed results: study - An experimental blood thinning drug made by the pharmaceutical gi... http://t.co/ehl1QPJo
Merck Anticlotting Drug's Latest Trial - WSJ.com
online.wsj.com — “A study showed the addition of Merck & Co.'s anticlotting drug vorapaxar to standard care reduced the risk of heart attacks and related events by 13% in heart-disease patients—but increased the risk of significant bleeding by 66%.” View full resource at online.wsj.com
Most Recently Shared on March 24, 2012 at 3:12 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Merck Anticlotting Drug Shows Benefit and Risk - Wall Street Journal http://t.co/sJ9PkaHd #health
Aspirin Might Reduce Cancer Risk, But It Has Risks, Too : Shots - Health Blog : NPR
npr.org — “A review of hundreds of studies found that people who take aspirin daily lowered their risk of several cancers, but the jury's still out. And daily aspirin use also has major drawbacks — including the risk of serious internal bleeding — that may outweigh the benefits.” View full resource at npr.org
Most Recently Shared on March 22, 2012 at 11:34 am By:
Deborah Heiser Psychologist, PhD, and Doctor
NPR: Aspirin Might Reduce Cancer Risk, But It Has Risks, Too #health-More at http://t.co/JDqmOJ6l
Aspirin Might Reduce Cancer Risk, But It Has Risks, Too : Shots - Health Blog : NPR
npr.org — “A review of hundreds of studies found that people who take aspirin daily lowered their risk of several cancers, but the jury's still out. And daily aspirin use also has major drawbacks — including the risk of serious internal bleeding — that may outweigh the benefits.” View full resource at npr.org
Most Recently Shared on March 21, 2012 at 7:40 pm By:
Aspirin Might Reduce Cancer Risk, But It Has Risks, Too http://t.co/jvGZ8m7b
Studies Link Aspirin Daily Use to Reduced Cancer Risk - NYTimes.com
nytimes.com — “The findings add to evidence suggesting that aspirin may be a powerful if overlooked weapon against cancer, but some physicians and health officials are concerned about side effects.” View full resource at nytimes.com
Most Recently Shared on March 21, 2012 at 5:40 am By:
Eric Topol, MD Doctor, Internist, Cardiologist, and Physician
Population medicine- low dose aspirin protects from cancer+ mets, vs risk of bleeding. Need 2 know who really benefits! http://t.co/gt66EiwJ
Bleeding After Dental Extractions In Cardiac Patients On Anticoagulants Reduced By Protocol
medicalnewstoday.com — “Clinicians need a protocol to reduce the risk of substantial bleeding after dental extractions in cardiac patients who take anticoagulant medications. Findings in a study published in the current” View full resource at medicalnewstoday.com
Most Recently Shared on December 21, 2011 at 10:05 am By:
Bleeding After Dental Extractions In Cardiac Patients On Anticoagulants Reduced By Protocol http://t.co/4v7YSj79 #healthnews
Drug-Coated Balloons Open Arteries Blocked by Narrowed Stents - Drugs.com MedNews
drugs.com — “Balloons coated with a drug used to open blocked stents in heart arteries restore blood flow and also reduce bleeding in some high-risk patients, new research s” View full resource at drugs.com
Most Recently Shared on November 16, 2011 at 5:24 pm By:
Drug-Coated Balloons Open Arteries Blocked by Narrowed Stents - http://t.co/jt4dpGDO
AHA: Novel Antiplatelet Increases Bleeding in ACS (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “ORLANDO (MedPage Today) -- Giving a novel antiplatelet, vorapaxar, to acute coronary syndrome patients did not reduce mortality or serious cardiovascular events, but it did significantly increase the risk of major bleeding, including intracranial hemorrhage, researchers said here.” View full resource at qualitypointtech.net
Most Recently Shared on November 13, 2011 at 3:00 pm By:
AHA: Novel Antiplatelet Increases Bleeding in ACS (CME/CE): ORLANDO (MedPage Today) -- Giving a novel antiplatelet... http://t.co/NSjAGoDh
Eliquis Beats Warfarin In Phase 3 Trial For Atrial Fibrillation Patients - QualityPoint Technologies
qualitypointtech.net — “A Phase III clinical trial, known as ARISTOTLE, found Eliquis (apixaban) to be better than Warfarin in reducing stroke or systemic embolism risk in patients with atrial fibrillation - there was also considerably less bleeding among the Eliquis patients. ARISTOTLE showed that Eliquis is the number one oral blood thinner to considerably lower all-cause-death...” View full resource at qualitypointtech.net
Most Recently Shared on August 28, 2011 at 7:45 pm By:
Eliquis Beats Warfarin In Phase 3 Trial For Atrial Fibrillation Patients: A Phase III clinical trial, known as ARI... http://t.co/uL6dbbm
WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events
news-medical.net — “Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.” View full resource at news-medical.net
Most Recently Shared on July 30, 2011 at 8:54 am By:
Medicare News: WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse ... http://bit.ly/r42Vqd
Advertisement
